These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 9817625)

  • 1. Personality disorder comorbidity with major depression and response to treatment with sertraline or citalopram.
    Ekselius L; von Knorring L
    Int Clin Psychopharmacol; 1998 Sep; 13(5):205-11. PubMed ID: 9817625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic depression and comorbid personality disorders: response to sertraline versus imipramine.
    Russell JM; Kornstein SG; Shea MT; McCullough JP; Harrison WM; Hirschfeld RM; Keller MB
    J Clin Psychiatry; 2003 May; 64(5):554-61. PubMed ID: 12755659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in personality traits during treatment with sertraline or citalopram.
    Ekselius L; Von Knorring L
    Br J Psychiatry; 1999 May; 174():444-8. PubMed ID: 10616614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Citalopram versus sertraline in late-life nonmajor clinically significant depression: a 1-year follow-up clinical trial.
    Rocca P; Calvarese P; Faggiano F; Marchiaro L; Mathis F; Rivoira E; Taricco B; Bogetto F
    J Clin Psychiatry; 2005 Mar; 66(3):360-9. PubMed ID: 15766303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind multicenter trial comparing sertraline and citalopram in patients with major depression treated in general practice.
    Ekselius L; von Knorring L; Eberhard G
    Int Clin Psychopharmacol; 1997 Nov; 12(6):323-31. PubMed ID: 9547134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of response to acute treatment of chronic and double depression with sertraline or imipramine.
    Hirschfeld RM; Russell JM; Delgado PL; Fawcett J; Friedman RA; Harrison WM; Koran LM; Miller IW; Thase ME; Howland RH; Connolly MA; Miceli RJ
    J Clin Psychiatry; 1998 Dec; 59(12):669-75. PubMed ID: 9921701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Placebo-controlled comparison of the selective serotonin reuptake inhibitors citalopram and sertraline.
    Stahl SM
    Biol Psychiatry; 2000 Nov; 48(9):894-901. PubMed ID: 11074227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Escitalopram versus sertraline in the treatment of major depressive disorder: a randomized clinical trial.
    Ventura D; Armstrong EP; Skrepnek GH; Haim Erder M
    Curr Med Res Opin; 2007 Feb; 23(2):245-50. PubMed ID: 17288677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sertraline versus paroxetine in major depression: clinical outcome after six months of continuous therapy.
    Aberg-Wistedt A; Agren H; Ekselius L; Bengtsson F; Akerblad AC
    J Clin Psychopharmacol; 2000 Dec; 20(6):645-52. PubMed ID: 11106136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A target trial emulation comparing the antidepressant effectiveness of selective serotonin reuptake inhibitors (SSRIs) highlighting the importance of patent-related confounding by indication.
    Rohde C; Hieronymus F; Østergaard SD
    Acta Psychiatr Scand; 2024 Oct; 150(4):198-208. PubMed ID: 38994727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of pharmacotherapy on personality disorders in panic disorder: a one year naturalistic study.
    Marchesi C; Cantoni A; Fontò S; Giannelli MR; Maggini C
    J Affect Disord; 2005 Dec; 89(1-3):189-94. PubMed ID: 16209891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Faster onset of antidepressant effects of citalopram compared with sertraline in drug-naïve first-episode major depressive disorder in a Chinese population: a 6-week double-blind, randomized comparative study.
    Hsu JW; Su TP; Huang CY; Chen YS; Chou YH
    J Clin Psychopharmacol; 2011 Oct; 31(5):577-81. PubMed ID: 21869697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of comorbid obsessive-compulsive and depressive disorders in children age].
    Goriunov AV; Lobacheva MV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(11 Pt 2):48-52. PubMed ID: 23257756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of dysthymia with sertraline: a double-blind, placebo-controlled trial in dysthymic patients without major depression.
    Ravindran AV; Guelfi JD; Lane RM; Cassano GB
    J Clin Psychiatry; 2000 Nov; 61(11):821-7. PubMed ID: 11105734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter double-blind comparison of sertraline and desipramine for concurrent obsessive-compulsive and major depressive disorders.
    Hoehn-Saric R; Ninan P; Black DW; Stahl S; Greist JH; Lydiard B; McElroy S; Zajecka J; Chapman D; Clary C; Harrison W
    Arch Gen Psychiatry; 2000 Jan; 57(1):76-82. PubMed ID: 10632236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness and acceptability of sertraline and citalopram in major depressive disorder: pragmatic randomized open-label comparison.
    Matreja PS; Badyal DK; Khosla P; Deswal RS
    Hum Psychopharmacol; 2007 Oct; 22(7):477-82. PubMed ID: 17647298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Torin (sertraline) in the treatment of depressive and obsessive-compulsive disorders in children].
    Malinina EV; Zabozlaeva IV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(8):22-4. PubMed ID: 20823825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SSRIs in the treatment of depression in Parkinson's disease.
    Leentjens AF; Vreeling FW; Luijckx GJ; Verhey FR
    Int J Geriatr Psychiatry; 2003 Jun; 18(6):552-4. PubMed ID: 12789682
    [No Abstract]   [Full Text] [Related]  

  • 19. The effects of sertraline on psychopathic traits.
    Dunlop BW; DeFife JA; Marx L; Garlow SJ; Nemeroff CB; Lilienfeld SO
    Int Clin Psychopharmacol; 2011 Nov; 26(6):329-37. PubMed ID: 21909028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-compliance with pharmacotherapy of depression is associated with a sensation seeking personality.
    Ekselius L; Bengtsson F; von Knorring L
    Int Clin Psychopharmacol; 2000 Sep; 15(5):273-8. PubMed ID: 10993129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.